Came competitive analysis

Explore patent oppositions filed by Came against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition Date
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEApr 16, 2025
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
Structural Improvements Of Low Voltage Underground Link BoxesTYCO ELECTRONICS UKFeb 10, 2023
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)FRED HUTCHINSON CANCER CENTEROct 12, 2022
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALSAug 6, 2020
Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1VENTANA MEDICAL SYSTEMSOct 9, 2019
Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKSep 26, 2019
Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3VENTANA MEDICAL SYSTEMSJul 10, 2019

Explore Came's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleTotal Oppositions
May 29, 2024Light-Signaling Device For Access Points1
Apr 24, 2019Power And Signal Distribution System1
Oct 3, 2018Power And Signal Distribution System1

Latest PTAB cases involving Came

Discover the latest PTAB cases involving Came, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 14, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Came

IPR2025-00155Nov 7, 2024TROVE BRANDSCAMELBAK PRODUCTSInstitution Denied
IPR2025-00140Nov 5, 2024TROVE BRANDSCAMELBAK PRODUCTSFinal Written Decision
IPR2025-00146Nov 5, 2024TROVE BRANDSCAMELBAK PRODUCTSInstitution Denied
IPR2024-01501Sep 30, 2024TROVE BRANDSCAMELBAK PRODUCTSInstitution Denied
IPR2024-01137Jul 1, 2024TROVE BRANDSCAMELBAK PRODUCTSFinal Written Decision - Appealed
PGR2024-00033May 22, 2024CAMEL MANUFACTURINGDLX ENTERPRISESTerminated-Settled
IPR2022-00803Apr 19, 2022ZAK DESIGNSCAMELBAK PRODUCTSInstitution Denied
IPR2020-00691Mar 9, 2020NITRO FLUIDSCAMERONInstitution Denied
IPR2019-00852Mar 20, 2019NITRO FLUIDSCAMERONFinal Written Decision
IPR2019-00804Mar 8, 2019NITRO FLUIDSCAMERONInstitution Denied

Peer Comparison New

IP litigation analysis comparing Came with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 9, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CMS CAMERON MCKENNA NABARRO OLSWANG11 - - -
NOVO NORDISK912819
SALIX PHARMACEUTICALS - 19 - 3
VENTANA MEDICAL SYSTEMS - 3 - -